Graft Dysfunction: Clinical Trials

8 trials for Graft Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed, 1 active not recruiting, 1 terminated. 3 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Active not recruiting 1
Phase 21Terminated 1
Phase 31Terminated 1
Phase 41Completed 1

Follow Graft Dysfunction: new trials by email Literature Review of Graft Dysfunction trials Research Report on Graft Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prediction of Lung Transplant Outcome
Research Blood Sampling and Biocollection - Graft Dysfunction, Lung Transplantation
Not applicableActive not recruitingHopital Foch42002025-06-172026-01-21
Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation
End-ischemic normothermic oxygenated machine perfusion, Static cold storage - Kidney Transplant; Complications, Kidney Failure
Not applicableUnknownCharite University, Berlin, Germany1942022-05-102022-06-13
The Effect of Intraoperative Arterial Oxygen Pressures on Early Post-Operative Patient and Graft Survival in Living Donor Kidney Transplantation
Arterial blood gas samples - Kidney Transplant; Complications, Hyperoxia
CompletedAkdeniz University2472020-05-012020-12-02
Heart Failure After Heart Transplantation Due to Chronic Rejection
Diagnostic investigations - Cardiac Allograft Vasculopathy, Chronic Rejection of Cardiac Transplant
Not applicableUnknownSahlgrenska University Hospital1002019-01-012019-01-17
EPI-STORM: Cytokine Storm in Organ Donors
No intervention - Organ Donation, Liver Transplantation
UnknownUniversité de Sherbrooke1052018-12-162025-04-02
Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK
Graft Dysfunction
UnknownUniversity Hospital, Strasbourg, France1702016-07-012017-01-06
Novartis Everolimus Transition
Everolimus, Standard of Care - Graft Dysfunction, Interstitial Fibrosis
Phase 4CompletedMedical University of South Carolina602014-02-012018-08-08
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
Tacrolimus, HTK/Placebo - Terminal Liver Disease, Ischemia Reperfusion Injury
Phase 2 / Phase 3TerminatedLudwig-Maximilians - University of Munich252011-10-012017-03-23

Narrower conditions

Hyperoxia (1)  ·  Kidney Diseases (1)  ·  Pulmonary Fibrosis (1)  ·  Rejection, Psychology (1)  ·  Renal Insufficiency (1)  ·  Reperfusion Injury (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Fibrosis (1)  ·  Kidney Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Postoperative Complications (1)  ·  Respiratory Tract Diseases (1)

Interventions

Everolimus (1)  ·  Receptor, EphB4 (1)  ·  Standard of Care (1)  ·  Tacrolimus (1)

Sponsors

Akdeniz University (1)  ·  Charite University, Berlin, Germany (1)  ·  Hopital Foch (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  Medical University of South Carolina (1)  ·  Sahlgrenska University Hospital (1)  ·  University Hospital, Strasbourg, France (1)  ·  Université de Sherbrooke (1)

Countries

France (2)  ·  Germany (2)  ·  Canada (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Antoine Roux, Pr (1)  ·  David Taber (1)  ·  Karl-Walter Jauch, M.D. (1)  ·  Martin Angele, M.D. (1)  ·  Sebastian Pratschke, M.D. (1)  ·  Titte Srinivas, MD (1)

Results publications

PMID 23497558, PMID 27500266, PMID 31365151, PMID 33398714, PMID 35603508, PMID 38979743